Singapore Clinical Trial: A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asciminib in pediatric participants newly diagnosed or previously treated with Philadelphia positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) with or without known T315I mutation.

Singapore, Sept. 26 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asci... और पढ़ें

Singapore Clinical Trial: A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib with chemotherapy followed by asciminib plus blinatumomab in pediatric, adolescent, and young adult participants with relapsed or refractory BCR::ABL1-positive (Philadelphia positive, Ph+) or BCR::ABL1-like (Ph-like) acute lymphoblastic leukemia (ALL)

Singapore, Sept. 26 -- The Health Sciences Authority received information related to the study titled 'A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib wit... और पढ़ें

Singapore Clinical Trial: A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy versus placebo with chemotherapy in patients with previously untreated locally recurrent inoperable or metastatic TNBC determined ineligible for PD(L)1 therapy based on PD-L1 negative disease

Singapore, Sept. 26 -- The Health Sciences Authority received information related to the study titled 'A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy... और पढ़ें

Singapore Clinical Trial: CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitaxel and Gemcitabine versus Placebo in Combination with Nab-paclitaxel and Gemcitabine in Participants with Untreated Metastatic Pancreatic Ductal Adenocarcinoma Harboring Homozygous MTAP Deletion

Singapore, Sept. 26 -- The Health Sciences Authority received information related to the study titled 'CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitax... और पढ़ें

'I couldn't say no': Prithviraj Sukumaran reveals why Kareena Kapoor Khan made him say yes to Daayra

India, Sept. 26 -- Prithviraj Sukumaran opens up about why he said yes to Meghna Gulzar's Daayra, the film's exploration of conflicting perspectives on justice, and the uncomfortable questions it leav... और पढ़ें

Rohit Sharma, Virat Kohli meet specially-abled kid in Kerala, gesture wins hearts - Watch

India, Sept. 26 -- Rohit Sharma and Virat Kohli will return to action on Sunday with the three-match ODI series against the West Indies. The duo last played for India in the UK, but the series saw the... और पढ़ें

Maharashtra: Over 500 evacuated after heavy rain in Chhattisgarh triggers floods in Gadchiroli

Gadchiroli, Sept. 26 -- Around 525 people have been evacuated to safer locations in Maharashtra's Gadchiroli district following severe flooding triggered by heavy rainfall in neighbouring Chhattisgarh... और पढ़ें

India Weighs Rs.20,000 Crore Fund to Scale AI and Compute

New Delhi, Sept. 26 -- India has spent the past two years expanding access to the computing power needed to build artificial intelligence. The IndiaAI Mission initially set out to create access to mor... और पढ़ें

The Vvaan box office collection day 2: Sidharth Malhotra, Tamannaah Bhatia film shows growth, crosses rRs.r19 crore

India, Sept. 26 -- The Vvaan box office collection day 2: Sidharth Malhotra and Tamannaah Bhatia's The Vvaan - Force of the Forrest has released in theatres on Friday. The film opened to mixed reviews... और पढ़ें

The Vvaan box office collection day 2: Sidharth Malhotra, Tamannaah Bhatia film shows growth, brings in rRs.r19 crore

India, Sept. 26 -- The Vvaan box office collection day 2: Sidharth Malhotra and Tamannaah Bhatia's The Vvaan - Force of the Forrest has released in theatres on Friday. The film opened to mixed reviews... और पढ़ें

• ««
• «
• 6607
• 6608
• 6609
• 6610
• 6611
• 6612
• 6613
• 6614
• 6615
• 6616
• »
• »»